Par Drugs And Stock Shares Outstanding
| PAR Stock | 97.28 0.57 0.58% |
Par Drugs And fundamentals help investors to digest information that contributes to Par Drugs' financial success or failures. It also enables traders to predict the movement of Par Stock. The fundamental analysis module provides a way to measure Par Drugs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Par Drugs stock.
As of March 24, 2025, Common Stock Shares Outstanding is expected to decline to about 11.2 M. Par | Shares Outstanding |
Par Drugs And Company Shares Outstanding Analysis
Par Drugs' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Par Drugs Shares Outstanding | 12.3 M |
Most of Par Drugs' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Par Drugs And is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Par Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Par Drugs And has 12.3 M of shares currently outstending. This is 93.18% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all India stocks is 97.85% higher than that of the company.
Par Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Par Drugs' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Par Drugs could also be used in its relative valuation, which is a method of valuing Par Drugs by comparing valuation metrics of similar companies.Par Drugs is currently under evaluation in shares outstanding category among its peers.
Par Fundamentals
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.14 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 1.02 B | ||||
| Shares Outstanding | 12.3 M | ||||
| Price To Book | 1.24 X | ||||
| Price To Sales | 1.19 X | ||||
| Revenue | 956.4 M | ||||
| Gross Profit | 649.91 M | ||||
| EBITDA | 229.53 M | ||||
| Net Income | 145.01 M | ||||
| Total Debt | 159.79 M | ||||
| Book Value Per Share | 78.69 X | ||||
| Cash Flow From Operations | 202.49 M | ||||
| Earnings Per Share | 12.53 X | ||||
| Number Of Employees | 122 | ||||
| Beta | 0.12 | ||||
| Market Capitalization | 1.2 B | ||||
| Total Asset | 1.02 B | ||||
| Retained Earnings | 625.51 M | ||||
| Working Capital | 471.85 M | ||||
| Net Asset | 1.02 B |
About Par Drugs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Par Drugs And's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Par Drugs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Par Drugs And based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Par Stock
Par Drugs financial ratios help investors to determine whether Par Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Par with respect to the benefits of owning Par Drugs security.